DZHK financed and Associated Studies

Systolic dysfunction to congestive heart failure cohort study (TransitionCHF-DZHK2)

This cohort study explores ways of predicting when decreased cardiac performance without symptoms will develop into a clinically manifest disease. In many patients, decreased cardiac performance is detected during routine examinations without the patient showing any of the typical symptoms, such as a reduction in exercise tolerance or shortness of breath. This ‘hidden’ heart failure can be caused by high blood pressure, myocardial infarction or diseases of the heart muscle. Some 1,000 such patients are to be examined and followed over a period of at least five years at the DZHK partner sites and at other clinics.

Within the scope of the study, blood markers, results from imaging studies and genetic profiles will be analysed in relation to the patients’ state of health and development of clinical symptoms. The emerging patterns and regularities could be used in the future to help predict when symptoms of heart failure will appear. Then therapeutic measures could be taken to counter the development of symptoms. This is all the more important because heart failure generally progresses gradually and clinicians have so far not found a way to prevent further deterioration of the condition.

TransitionCHF-DZHK2 - Systolic dysfunction to congestive heart failure cohort study (TransitionCHF-DZHK2)

Publications

There are no publications available yet.

Principal Investigators

Principal investigator: Gerd Hasenfuß (Göttingen), Co-PI: Rolf Wachter (Leipzig), Anja Sandek (Göttingen), Frank Edelmann (Berlin)

Study recruitment is available in these cities

The map only displays recruitment locations within Germany.

Study information
TransitionCHF-DZHK2

Recruiting status
Recruiting complete, follow-up continuing
Recruitment start
12.2014
Patients
1016
1000
Clinical Trials Registrierung

NCT02323750

Category
Cohort
DZHK Funding
€ 1.786.872

Operative contact
Main study centre - Dr. Christoph Gertler
christoph.gertler@med.uni-goettingen.de

Studienzentren/Kontakt (PDF)

Do you want to associate your clinical trial with us?

Clinical studies that are not DZHK-financed can receive the status "DZHK-associated" if their objectives match our research interest. By associating, we support the study ideally, for example, by promoting recruitment through our network.

Please contact clinicalstudies@dzhk.de for further information.

Study Participation

Would you like to participate in a DZHK study or learn more about our clinical studies? The Patient Information Platform (PIP) informs patients, relatives and interested individuals about our clinical studies.

Learn more (German only)

Contact

Alexandra Klatt
Coordinator Clinical Research
Phone: +49 (0)30 3465 529 10 
alexandra.klatt@dzhk.de